La deficiencia de vitamina D es un factor de riesgo de mortalidad en pacientes con COVID-19

Fonte: La deficiencia de vitamina D es un factor de riesgo de mortalidad en pacientes con COVID-19


“Conclusión: Los pacientes con COVID-19 que requieren hospitalización tienen deficiencia de vitamina D, y niveles de bajo de 8 ng/mL es un factor de riesgo para mortalidad por COVID-19, por lo que se deben tomar acciones que mejoren los niveles de vitamina D como la suplementación de vitamina D en este grupo de pacientes.”



  1. Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, a worldwide public health emergency [published online ahead of print, 2020 Mar 20]. COVID-19, una emergencia de salud pública mundial [published online ahead of print, 2020 Mar 20]. Rev Clin Esp. 2020;S0014-2565(20)30092-8. doi:10.1016/j.rce.2020.03.001
  2. Grant, WB; Lahore, H .; McDonnell, SL; Baggerly, CA; Francés, CB; Aliano, JL; Bhattoa, HP Evidencia de que la suplementación con vitamina D podría reducir el riesgo de influenza e infecciones y muertes por COVID-19. Nutrientes 2020 , 12 , 988
  3. Study and fight Coronavirus with research tools from PromoCell. PromoCell. 2020. Available in:
  4. Kechichian E, Ezzedine K. Vitamin D and the skin: an update for dermatologists. Am J Clin Dermatol. 2018; 19 (2): 223-235. Available in:
  5. Hossein-Nezhad A, Holick M. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013; 88 (7): 720-755. Available in:
  6. Holick MF. Medical progress: vitamin D deficiency. N Engl J Med. 2007; 357 (3): 266-281. Available in:
  7. Varsavskya M, Rozas P, Becerra A, Luque I, Quesada JM, Ávila V et al. Recomendaciones de vitamina D para la población general. Endocrinol Diabetes Nutr. 2017; 64: 7-14. Disponible en;
  8. Grant, WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020; 12 (4): 988. Available in:
  9. Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality [published online ahead of print, 2020 May 6]. Aging Clin Exp Res. 2020; 1-4. Available in:
  10. Teymoori-Rad M, Shokri F, Salimi V, Marashi SM. The interplay between vitamin D and viral infections. Rev Med Virol. 2019; 29 (2): e2032. Available in:
  11. Cui C, Xu P, Li G, Qiao Y, Han W, Geng C et al Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system. Redox Biol. 2019; 26: 101295. Available in:
  12. Soler MJ, Lloveras J, Batlle D. Enzima conversiva de la angiotensina 2 y su papel emergente en la regulación del sistema renina-angiotensina. Medicina Clínica. 2008; 131 (6): 230-236. Disponible en:
  13. Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012; 2012: 256294. Available in:
  14. Información General. Covid-19 México. 2020. Disponible en:
  15. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020; 395 (10229): 1054-1062.
  16. Lips P, Cashman K, Lamberg-Allardt C, Bischoff-Ferrari H, Obermayer-Pietsch B, Bianchi ML et al. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. Eur J Endocrinol. 2019; 180 (4): 23-54. Available in:
  17. Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134(6):1129-1140. doi:10.1017/S0950268806007175
  18. Spiro A, Buttriss JL. Vitamin D: an overview of vitamin D status and intake in Europe. Nutr Bull. 2014; 39 (4): 322-350. Available in:
  19. Sowah D, Fan X, Dennett L, Hagtvedt R, Straube S. Vitamin D levels and deficiency with different occupations: a systematic review. BMC Public Health. 2017; 17 (1): 519-544. Available in:
  20. Amrein K, Scherkl M, Hoffmann M, Neuwersch S, Köstenberger M, Tmava A et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020; 1-16. Available in:
  21. Ianevski A, Zusinaite E, Shtaida N, Kallio-Kokko H, Valkonen M, Kantele A et al. Low temperature and low UV indexes correlated with peaks of influenza virus activity in Northern Europe during 2010-2018. Viruses. 2019; 11 (3): 207-216. Available in:
  22. Richardson S, Hirsch JS, Narasimhan M et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area [published online ahead of print, 2020 Apr 22]. JAMA. 2020; e206775. doi: 10.1001/jama.2020.6775.
  23. Raharusun P, Priambada S, Budiarti C, Agung E, Budi C. Patterns of COVID-19 Mortality and Vitamin D: An Indonesian Study. 2020.
  24. Rhodes JM, Subramanian S, Laird E, Kenny RA. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment Pharmacol Ther. 2020; 51 (12): 1434-1437. Available in:
  25. Marik PE, Kory P, Varon J. Does vitamin D status impact mortality from SARS-CoV-2 infection? [published online ahead of print, 2020 Apr 29]. Med Drug Discov. 2020; 100041. doi: 10.1016/j.medidd.2020.100041.
  26. Rhodes LE, Webb AR, Fraser HI, Kift R, Durkin MT, Allan D et al. Rhodes LE, Webb AR, Fraser HI, et al. Recommended summer sunlight exposure levels can produce sufficient (> or =20 ng ml(-1)) but not the proposed optimal (> or =32 ng ml(-1)) 25(OH)D levels at UK latitudes. J Invest Dermatol. 2010; 130 (5): 1411-1418. Available in:
  27. Khan QJ, Fabian CJ. How I treat vitamin d deficiency. J Oncol Pract. 2010; 6 (2): 97-101.